Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors
Nai Jung Chiang
(Contributor)
Tsu-Yi Chao
(Contributor)
Ruey Kuen Hsieh
(Contributor)
C. H. Wang
(Creator)
Yi Wen Wang
(Creator)
C. Grace Yeh
(Contributor)
Li Tzong Chen
(Contributor)
TMU Research Center of Cancer Translational Medicine
Taipei Medical University Shuang Ho Hospital
Department of Internal Medicine
Graduate Institute of Clinical Medicine
Dataset
Overview
Research output
(1)
Research output
Research output per year
2016
2016
2016
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2016
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors
Chiang, N. J.
,
Chao, T. Y.
,
Hsieh, R. K.
,
Wang, C. H.
,
Wang, Y. W.
,
Yeh, C. G.
&
Chen, L. T.
,
Nov 21 2016
,
In:
BMC Cancer.
16
,
1
, 907.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Leucovorin
100%
Irinotecan
98%
Liposomes
82%
Fluorouracil
79%
Injections
48%
29
Citations (Scopus)